EI
Ellevest Inc’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $447K | Buy |
851
+464
| +120% | +$244K | 0.07% | 217 |
|
|
2025
Q1 | $245K | Sell |
387
-155
| -29% | -$98.3K | 0.02% | 334 |
|
|
2024
Q4 | $386K | Buy |
542
+202
| +59% | +$144K | 0.02% | 256 |
|
|
2024
Q3 | $357K | Buy |
340
+33
| +11% | +$34.7K | 0.02% | 288 |
|
|
2024
Q2 | $323K | Sell |
307
-6
| -2% | -$6.31K | 0.02% | 305 |
|
|
2024
Q1 | $301K | Buy |
313
+4
| +1% | +$3.85K | 0.02% | 311 |
|
|
2023
Q4 | $271K | Sell |
309
-75
| -20% | -$65.9K | 0.02% | 313 |
|
|
2023
Q3 | $316K | Sell |
384
-232
| -38% | -$191K | 0.02% | 255 |
|
|
2023
Q2 | $443K | Buy |
616
+127
| +26% | +$91.3K | 0.03% | 177 |
|
|
2023
Q1 | $402K | Buy |
489
+81
| +20% | +$66.6K | 0.03% | 180 |
|
|
2022
Q4 | $294K | Buy |
408
+11
| +3% | +$7.94K | 0.02% | 235 |
|
|
2022
Q3 | $273K | Sell |
397
-43
| -10% | -$29.6K | 0.03% | 207 |
|
|
2022
Q2 | $260K | Buy |
440
+6
| +1% | +$3.55K | 0.02% | 232 |
|
|
2022
Q1 | $303K | Buy |
434
+207
| +91% | +$145K | 0.03% | 235 |
|
|
2021
Q4 | $143K | Buy |
227
+1
| +0.4% | +$630 | 0.01% | 342 |
|
|
2021
Q3 | $137K | Buy |
226
+33
| +17% | +$20K | 0.01% | 343 |
|
|
2021
Q2 | $108K | Buy |
193
+178
| +1,187% | +$99.6K | 0.01% | 361 |
|
|
2021
Q1 | $7K | Sell |
15
-175
| -92% | -$81.7K | ﹤0.01% | 850 |
|
|
2020
Q4 | $92K | Buy |
190
+38
| +25% | +$18.4K | 0.01% | 329 |
|
|
2020
Q3 | $85K | Sell |
152
-4
| -3% | -$2.24K | 0.02% | 297 |
|
|
2020
Q2 | $97K | Buy |
156
+127
| +438% | +$79K | 0.02% | 215 |
|
|
2020
Q1 | $14K | Buy |
29
+18
| +164% | +$8.69K | ﹤0.01% | 493 |
|
|
2019
Q4 | $4K | Buy |
11
+2
| +22% | +$727 | ﹤0.01% | 622 |
|
|
2019
Q3 | $2K | Buy |
+9
| New | +$2K | ﹤0.01% | 348 |
|